IRYCIS Outstanding publication

• Tuesday, 21 January 2025

  Gioia F, Walti LN, Orchanian-Cheff A, Husain S. Risk factors for COVID-19-associated pulmonary aspergillosis: a systematic review and meta-analysis

  Lancet Respir Med. 2024

  10.1016/S2213-2600(23)00408-3

• Tuesday, 14 January 2025

  Levin BR, Berryhill BA, Gil-Gil T, Manuel JA, Smith AP, Choby JE, Andersson DI, Weiss DS, Baquero F. Theoretical considerations and empirical predictions of the pharmaco- and population dynamics of heteroresistance

  Proc Natl Acad Sci U S A. 2024

  10.1073/pnas.2318600121

• Wednesday, 8 January 2025

  Ruz-Caracuel I, Caniego-Casas T, Alonso-Gordoa T, Carretero-Barrio I, Ariño-Palao C, Santón A, Rosas M, Pian H, Molina-Cerrillo J, Luengo P, Palacios J. Transcriptomic Differences in Medullary Thyroid Carcinoma According to Grade

  Endocr Pathol. 2024

  10.1007/s12022-024-09817-0

• Tuesday, 17 December 2024

  Alcalá S, Villarino L, Ruiz L, Couceiro JR, Martínez M, Palencia A, Navarro D, Cabezas P, Rodriguez I, Cordero A, Trilla L, Rubiolo JA, Batres S, Vallespinos M, González C, Rodríguez J, Gámez A, Vara J, Fernández SF, Berlinches AB, Moreno N, Redondo A, Carrato A, Hermann PC, Sánchez L, Torrente S, Fernández MÁ, Mascareñas JL, Sainz BJR. Targeting cancer stem cell OXPHOS with tailored ruthenium complexes as a new anti-cancer strategy

  J Exp Clin Cancer Res. 2024

  10.1186/s13046-023-02931-7